FDA Authorizes Emergency Use of Freeze-Dried Plasma Treatment for Military Combat Emergencies

Summary

The Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for a freeze-dried plasma treatment to address hemorrhage or coagulopathy in emergency situations involving military combat, such as firearms, projectiles, and explosive devices. This authorization was granted under the Federal Food, Drug, and Cosmetic Act (FD&C Act) at the request of the U.S. Department of Defense (DoD).